Status:

NOT_YET_RECRUITING

Testing SHAPE: A Single-Session Intervention Targeting Binge Eating in Women Through Assessment and Values-Based Strategies

Lead Sponsor:

Taylor Rezeppa

Collaborating Sponsors:

Ohio University

Conditions:

Binge Eating

Binge Eating Behaviour

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

The goal of this controlled trial is to learn whether a brief single-session intervention (SSI) can reduce binge eating symptoms by targeting overvaluation of weight/shape in women with recurrent bing...

Eligibility Criteria

Inclusion

  • ≥ 18 years old
  • Identify as cisgender female
  • self-reported BMI ≥ 18.5 kg/m²
  • Rate the extent to which their weight or shape influences how they feel about themselves as a "4" or higher on a 7-point Likert scale on screening measures
  • ≥1 binge eating episode every 2 weeks (i.e., ≥ six episodes over 3 months) at the time of screening

Exclusion

  • \< 18 years old
  • Assigned male at birth
  • Gender identity different from biological sex indicated on birth certificate
  • Purging behaviors (i.e., self-induced vomiting, laxative misuse, or diuretic misuse) ≥ 1x/week in the last 3 months at the time of screening.
  • Engaged in structured psychological therapy or counseling (defined as attending sessions \> 1x/month in the past 3 months)
  • Prior participation in studies that include administration of the EDE interview at Ohio University (IRB-FY24-403, IRB-FY25-330, and IRB-21-F-14).

Key Trial Info

Start Date :

October 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2027

Estimated Enrollment :

56 Patients enrolled

Trial Details

Trial ID

NCT07217847

Start Date

October 1 2025

End Date

May 1 2027

Last Update

October 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ohio University

Athens, Ohio, United States, 45705